Home
/ BiOZEEN
/ Competitors

BiOZEEN Competitors and Similar CompaniesClear all

BiOZEEN's competitors and similar companies include Kemwell Biopharma, Olink, Vectura Group and Glenmark Pharmaceuticals.

	BiOZEEN BiOZEEN (Bangalore Biotech Labs) is a biopharmaceutical company.	Kemwell Biopharma Kemwell Biopharma is a contract biologic development company.	Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery.	Vectura Group Vectura Group is a product development company that focuses on drug delivery.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 2005	Founding Date 1980	Founding Date 2004	Founding Date N/A	Founding Date 1977
Type	Type Private	Type Private	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Bengaluru, IN HQ	Locations Bengaluru, IN HQ	Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US	Locations Chippenham, GB HQ Saint Quentin Fallavier, FR Gauting, DE München, DE Muttenz, CH London, GB London, GB see more	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 3272% increase	Employees 5341% decrease	Employees 582	Employees 502	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $169.6m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ₹131.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $51.9m (FY, 2023)	Cost of goods N/A	Cost of goods ₹46.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $119.9m (FY, 2023)	Gross profit £2.3m (FY, 2022)	Gross profit ₹87b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($31.6m) (FY, 2023)	Net income (£158m) (FY, 2022)	Net income ₹10.5b (FY, 2025)